Introduction: This investigation determined whether improved physical function and decreased pain would reduce depressive symptoms using the Patient-reported Outcomes Measurement Information System (PROMIS). 
D
epression affects up to 20% of the general population. [1] [2] [3] In patients seeking orthopaedic care, the prevalence of depression reaches 33% to 45%. 4, 5 Orthopaedic patients with comorbid depression require longer hospital admissions, experience higher rates of long term pain, and report lower quality-of-life scores after treatment than patients without depression. [6] [7] [8] [9] Despite poorer perceived outcomes, patients with depression may experience similar improvements in physical function compared with those without depression, highlighting the complex relationship between mental health and physical outcomes. 10 Relevant studies in the orthopaedic literature have consistently focused on the effect of mental health and depressive symptoms on musculoskeletal outcomes. [11] [12] [13] [14] Therefore, it remains unclear how changes in musculoskeletal health resulting from orthopaedic care affect depressive symptoms.
This study was designed to determine whether improvement in self-reported physical function corresponds with an improvement in depressive symptoms using the Patient-reported Outcomes Measurement Information System (PROMIS) domains of Physical Function, Pain Interference, and Depression. PROMIS was developed by the National Institutes of Health as part of its Health Roadmap Initiative. PROMIS provides a robust tool with increased sensitivity through a wider range of health function because of PROMIS tools' utilization of a large pool of validated questions administered through computer adaptive testing (CAT). [15] [16] [17] [18] In this model, the initial response leads to the selection of the next question, which over the course of 4 to 12 questions results in a sensitive measure of function through a wide range of perceived mental and physical health. The PROMIS tools are not disease specific and examine the domains of physical, social, and mental health. Each PROMIS module is scored to produce a population normal mean score of 50 with an SD of 10 points (theoretical range, zero to 100) as based on scores from a general adult US census-matched population. Higher scores on each module represent more of the domain being measured such that higher scores are associated with greater physical function, more depression, and increased pain, respectively. Although any patient-reported outcome measure has inherent subjectivity, PROMIS assessments present questions asking the frequency and amount of difficulty associated with certain tasks that have been demonstrated to be reliable over time. 16, 19, 20 PROMIS has been validated as an effective screening tool for both depressive symptoms and physical function. [21] [22] [23] [24] Based on the literature documenting the negative association between selfreported physical function and depression, this study tested the null hypothesis that patients with improved physical function and pain after their orthopaedic treatment, as measured by an increase in PROMIS Physical Function and a decrease in PROMIS Pain Interference scores, respectively, would demonstrate a moderate correlation with improvement, or decrease, in PROMIS Depression scores.
Methods
This retrospective cohort study analyzed PROMIS scores drawn from a series of 37,697 consecutive initial outpatient clinic visits of adult patients presenting to a single tertiary orthopaedic clinic from June 22, 2015 , to August 1, 2016. An institutional review board exemption was confirmed, as all data were deidentified. All patients completed Flowchart of patients who met the inclusion and exclusion criteria for the study population.
electronic PROMIS Depression, Physical Function, and Pain Interference CAT on arrival. At check-in, patients received a tablet computer (iPad mini; Apple) that loaded the appropriate PROMIS health domain CATs for the patient to complete. This study gathered data from patients with a minimum of two office visits to our orthopaedic department during the inclusive study dates.
Because our primary aim was to determine whether improved perceived physical function or reduced pain interference was associated with lessened depressive symptoms, our inclusion criteria required patients to have demonstrated at least a moderate improvement in PROMIS Physical Function ($5 points; effect size, 0.5) between consecutive visits. This fivepoint cutoff was selected to approximate an estimated minimal clinically important difference in multiple PROMIS CATs, including Physical Function. 25, 26 Patients with an initial PROMIS Depression score of 35 (actual floor score indicating minimal depression 1.5 SD less than normal population) were excluded from analysis because improved Depression score is not possible given current scoring algorithms. Thus, 3,339 patients, with 6,678 visits, were eligible for inclusion ( Figure 1 ). Patients were not selected based on specific conditions or treatment delivered. The time between visits was not constant because consecutive visits with improvement in physical function were sufficient for inclusion.
Pairwise nonparametric correlations with Spearman rank correlation coefficients evaluated the relation of change in PROMIS scores from the first to second visit between all three modules. Nonparametric testing was chosen because the study's inclusion/exclusion criteria resulted in nonnormal score distributions. Potential correlations with patient age as well as the relationship between absolute PROMIS scores and the magnitude of change were tested similarly. Correlation coefficients (r) were interpreted as recommended by Calkins: 27 0.00 to 0.29 no correlation, 0.30 to 0.49 weak correlation, 0.50 to 0.69 moderate correlation, 0.70 to 0.89 strong correlation, and 0.90 to 1.00 very strong. One-way analysis of variance and the Student t-test analyzed the effect of race and sex, respectively, on the magnitude of change in Physical Function, Pain Interference, and Depression scores.
Multivariable linear regression analyses with forward selection assessed the effect of initial PROMIS Depression scores, change in PROMIS Pain Interference score, change in PROMIS Physical Function score, race, sex, and age on the magnitude of the change in PROMIS Depression scores between visits.
Subgroup analysis examined patients with initial Depression scores greater than the average for a general normative population mean (.50) and greater than one SD above the normative population mean (.60).
Results
The patients meeting inclusion criteria (PROMIS Physical Function improvement of at least five points between visits, Depression score .35) were comparable to the entire 
Conclusion
Baseline PROMIS Physical Function scores document worse perceived function as patients report more depressive symptoms (PROMIS Depression scores). This inverse relationship between perceived physical function and depression is consistent with investigations using other patient-reported outcome measures. 10, 14, 28 London et al 10 evaluated 256 patients with orthopaedic hand conditions and found that patients with higher levels of depression reported worse levels of function. Likewise, depression more strongly predicted poor functional status than radiographic or physical examination findings in a study that evaluated 72 patients with trapeziometacarpal arthritis. 28 In patients with full-thickness rotator cuff tears, Wylie et al 14 reported that mental health, as measured by SF-36 Mental Component Summary, was a stronger predictor of pain and shoulder outcome scores than rotator cuff tear size. Although both PROMIS Physical Function and Depression CATS are individually validated, 29 our results support that these domains capture an interaction between physical function and depression at presentation for care that has been demonstrated using other patient-reported health measures.
Although it is clear that mental and physical health are interrelated, the manner in which change in one domain may affect the other is less well understood. 10, 12, 30, 31 Callahan et al and others have determined that that treating depression could lead to an improvement in physical function. 30, 31 Meanwhile, our data suggest that improving physical function is not associated with substantial change in depressive symptoms measured by PROMIS, as improvement in Physical Function scores accounted for only 0.5% of the variance in change in Depression scores. There are several possible explanations for our findings. Although musculoskeletal dysfunction and pain are acknowledged to produce depressive symptoms, PROMIS Depression scores may more accurately reflect underlying depressive outlook as opposed to brief situational depression. To this end, it is notable that PROMIS Depression questions specifically assess symptoms within the past seven days, which would presumably have changed comparably to the change in physical function if indeed the musculoskeletal condition were the predominate source of the depressive symptoms. Second, this could be an indication that the relationship between physical function and mental health is less bidirectional than previously thought. Rather, poor mental health may affect one's perception of their physical health, but once poor physical health has triggered a change in mental health for the worse, 32 a subsequent improvement in physical health will not simply restore one's mental health. Finally, mental health changes that result from changes in physical function could lag behind and become apparent only with prolonged follow-up. Regardless of the cause, when using PROMIS scores in a clinical setting, it is important to recognize that early changes in physical function are not expected to substantially improve Depression scores.
We considered the potential bias toward finding that Depression scores changed little relative to Physical Function scores based on the inclusion of patients who reported less depressive symptoms than did the normative population. To determine whether this bias was present, we chose to analyze two subgroups of patients: those with Depression scores greater than the population mean (.50) and those with scores one SD greater than the mean (.60). This highest cutoff point was chosen for consistency with Pilkonis et al 33 who determined that the average PROMIS Depression score in a group of clinically depressed patients was 62. However, even when these subsets of patients were analyzed, no stronger association was found between improvement in physical function and improvement in depression.
Improvement in Pain Interference scores demonstrated some positive correlation with improvement in Depression scores in the subpopulation of patients reporting Depression scores over one SD greater than the normal population mean. Pain has long been known to be intimately associated with the development of depression. [34] [35] [36] Current research suggests that the descending pathways of pain modulation are affected by levels of norepinephrine and serotonin, the same neurotransmitters targeted by antidepressants. 37, 38 Clinically, patients with higher levels of depression are more likely to report higher scores on the Chronic Pain Grade. 34 Depressed patients are also more likely to report both more frequently recurrent and higher levels of postoperative pain after a variety of surgical procedures. 35 This study was conducted to broadly include all adult patients presenting for orthopaedic care. The large number of patients contributing data and the inclusion of patients from all orthopaedic specialties should strengthen the ability to generalize our results. However, there are several limitations inherent to our study. Current Procedural Terminology (CPT) codes were not available within this data set, and manual chart review was not feasible to determine specific treatment modalities, radiographic findings, or other clinical correlates. Therefore, we examined temporal changes between visits, rather than change after specific treatment. Furthermore, the times between consecutive office visits were not standardized although we were able to select a population reporting improved physical function with an effect size of at least 0.5. Data regarding antidepressant and pain medication use, as well as a clinical diagnosis of depression, were also unavailable, which could potentially confound the effect of improving physical function on depressive symptoms. It is also worth noting that, although PROMIS Depression scores can be translated into scores on other depression screening surveys, these scores are not intended to make the diagnosis of clinical depression. Patients with a clinical diagnosis of depression may report less transience of their depressive symptoms, and thus less improvement with improving pain or function. We anticipate continued research into the interrelationships of mental and physical health and investigation into the application of PROMIS in the clinical setting. Finally, although CAT improves the sensitivity and efficiency of PROMIS, this feature prohibits us from performing question level analysis because each patient may receive different questions within each health assessment.
PROMIS represents a substantial governmental effort to produce a unified collection of health domain assessments that may be used across specialties. Although PROMIS is well tested in the normal population, we are still working to better understand its performance in the clinical setting. Our data support the concept of interrelated perceptions of physical function, pain, and depressive symptoms at presentation but suggest that improved physical function is not consistently associated with less depressive symptoms. Thus, when used to assess populations of patients, PROMIS depression scores seem to capture an element of mental health and outlook, which is not modified by early improvement in physical function or pain after orthopaedic treatment.
